Free Trial

Procter & Gamble (NYSE:PG) Trading 0.5% Higher

The Procter & Gamble Company (NYSE:PG - Get Free Report) shares shot up 0.5% on Tuesday . The company traded as high as $166.04 and last traded at $165.31. 1,948,910 shares were traded during mid-day trading, a decline of 72% from the average session volume of 6,844,294 shares. The stock had previously closed at $164.44.

Analyst Ratings Changes

Several brokerages have recently commented on PG. Argus increased their price objective on Procter & Gamble from $180.00 to $185.00 and gave the stock a "buy" rating in a research note on Thursday, April 25th. StockNews.com lowered shares of Procter & Gamble from a "buy" rating to a "hold" rating in a research report on Thursday, February 29th. The Goldman Sachs Group started coverage on shares of Procter & Gamble in a report on Friday, March 1st. They set a "neutral" rating and a $168.00 price target on the stock. Stifel Nicolaus lifted their target price on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a "hold" rating in a research report on Wednesday, January 24th. Finally, Royal Bank of Canada upped their target price on Procter & Gamble from $156.00 to $157.00 and gave the company a "sector perform" rating in a report on Wednesday, January 24th. Seven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $169.76.


Read Our Latest Stock Report on Procter & Gamble

Procter & Gamble Trading Up 0.8 %

The firm's 50-day simple moving average is $160.23 and its 200-day simple moving average is $154.49. The firm has a market capitalization of $391.22 billion, a PE ratio of 27.09, a price-to-earnings-growth ratio of 3.34 and a beta of 0.43. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping analysts' consensus estimates of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The business had revenue of $20.20 billion for the quarter, compared to analysts' expectations of $20.43 billion. During the same period in the previous year, the firm earned $1.37 EPS. The business's quarterly revenue was up .6% on a year-over-year basis. Equities analysts expect that The Procter & Gamble Company will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a dividend of $1.0065 per share. This is a positive change from Procter & Gamble's previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.43%. The ex-dividend date of this dividend is Thursday, April 18th. Procter & Gamble's dividend payout ratio is currently 65.85%.

Insider Activity at Procter & Gamble

In related news, CEO Gary A. Coombe sold 22,000 shares of the firm's stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the completion of the sale, the chief executive officer now owns 36,845 shares of the company's stock, valued at $5,943,835.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, COO Shailesh Jejurikar sold 31,859 shares of the firm's stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $164.90, for a total transaction of $5,253,549.10. Following the completion of the transaction, the chief operating officer now owns 9,739 shares of the company's stock, valued at approximately $1,605,961.10. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Gary A. Coombe sold 22,000 shares of Procter & Gamble stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the completion of the transaction, the chief executive officer now directly owns 36,845 shares of the company's stock, valued at approximately $5,943,835.40. The disclosure for this sale can be found here. Insiders have sold a total of 118,724 shares of company stock worth $19,312,729 in the last 90 days. Company insiders own 0.17% of the company's stock.

Institutional Trading of Procter & Gamble

A number of institutional investors and hedge funds have recently bought and sold shares of PG. Wellington Management Group LLP boosted its position in shares of Procter & Gamble by 9.4% during the third quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company's stock valued at $5,193,916,000 after buying an additional 3,047,557 shares during the last quarter. Northern Trust Corp grew its stake in shares of Procter & Gamble by 2.3% in the third quarter. Northern Trust Corp now owns 29,313,150 shares of the company's stock worth $4,275,616,000 after acquiring an additional 670,862 shares during the period. Norges Bank purchased a new position in shares of Procter & Gamble during the fourth quarter valued at approximately $3,956,117,000. Charles Schwab Investment Management Inc. lifted its position in Procter & Gamble by 1.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 16,209,425 shares of the company's stock valued at $2,336,552,000 after purchasing an additional 206,165 shares during the period. Finally, Royal Bank of Canada boosted its holdings in Procter & Gamble by 3.2% in the third quarter. Royal Bank of Canada now owns 11,170,305 shares of the company's stock worth $1,629,299,000 after purchasing an additional 346,925 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Featured Articles and Offers

Search Headlines: